drugset / Trial / NCT00702858

Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer

NCT00702858 ↗

Completed 30 enrolled Legacy Health System
RandomizedCrossoverTriple-blindSupportive care

Summary

This purpose of this study is to determine if the herbal compound, Blue Citrus, decreases joint and bone pain associated with Aromotase Inhibitor therapy (AIT). Another purpose of the study is to find out if Blue Citrus improves how you feel while taking AIT and if your quality of life improves.

Timeline

Start
2008-04
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Blue Citrus Traditional medicine (herbal / TCM) 3500 mg —